Entries of Hellerbrand, C. on the publication server

Kurz, B., Arndt, S. , Unger, P., Ivanova, I. , Berneburg, Mark , Hellerbrand, C. and Karrer, Sigrid (2022) Association of polymorphous light eruption with NOD ‐2 and TLR ‐5 gene polymorphisms. Journal of the European Academy of Dermatology and Venereology 36 (11), pp. 2172-2180.

Dietrich, P., Kuphal, S., Spruss, T., Hellerbrand, C. and Bosserhoff, A. K. (2018) Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition. Oncogene 37 (7), pp. 897-911. Fulltext not available.

Roeb, E., Steffen, H., Bantel, H., Baumann, U., Canbay, A. , Demir, M., Drebber, U., Geier, A., Hampe, J. , Hellerbrand, C., Pathil-Warth, A., Schattenberg, J. , Schramm, C. , Seitz, H., Stefan, N. , Tacke, F., Tannapfel, A., Lynen Jansen, P. and Bojunga, J. (2015) S2k-Leitlinie nicht alkoholische Fettlebererkrankungen. Zeitschrift für Gastroenterologie 53 (07), pp. 668-723. Fulltext not available.

Dietrich, P., Moleda, Lukas, Kees, Frieder K., Müller, M., Straub, R. H. , Hellerbrand, C. and Wiest, R. (2013) Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y. Journal of hepatology 58 (2), pp. 254-261. Fulltext not available.

Buettner, R., Ascher, M., Gäbele, E., Hellerbrand, C., Kob, R., Bertsch, T. and Bollheimer, L. (2013) Olive Oil Attenuates the Cholesterol-induced Development of Nonalcoholic Steatohepatitis Despite Increased Insulin Resistance in a Rodent Model. Hormone and Metabolic Research 45 (11), pp. 795-801. Fulltext not available.

Valletta, D., Czech, B., Weiss, Thomas S. , Bosserhoff, A. and Hellerbrand, C. (2012) 316 FAT1 EXPRESSION IS INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTES TUMORIGENESIS. Journal of Hepatology 56 (2), S129. Fulltext not available.

Mahli, A., Saugspier, M., Thasler, W.E. and Hellerbrand, C. (2012) 1249 IN VITRO AND IN VIVO MODELS FOR CHEMOTHERAPY-ASSOCIATED STEATOHEPATITIS REVEAL AN EFFECT OF IRINOTECAN ON FATTY ACID BINDING PROTEIN EXPRESSION. Journal of Hepatology 56, S494. Fulltext not available.

Saugspier, M., Dorn, C. and Hellerbrand, C. (2012) 1260 AGING PROMOTES HEPATOCELLULAR STEATOSIS, INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS IN MICE. Journal of Hepatology 56, S498. Fulltext not available.

Dorn, C., Heilmann, J. and Hellerbrand, C. (2012) 163 XANTHOHUMOL SUPPRESSES HEPATIC INFLAMMATORY RESPONSE TO ACUTE LIVER INJURY. Journal of Hepatology 56, S72. Fulltext not available.

Czech, B., Saugspier, M., Dettmer, K. , Stevens, A., Dorn, C., Valletta, D., Bosserhoff, A., Oefner, P.J. and Hellerbrand, C. (2012) 364 DOWNREGULATION OF METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) EXPRESSION IN CHRONIC LIVER DISEASE PROMOTES HEPATIC INFLAMMATION AND FIBROSIS. Journal of Hepatology 56, S147-S148. Fulltext not available.

Valletta, D., Czech, B., Saugspier, M., Dorn, C., Bosserhoff, A. and Hellerbrand, C. (2012) 403 EXPRESSION AND FUNCTION OF THE ATYPICAL CADHERIN FAT1 IN HEPATIC FIBROSIS. Journal of Hepatology 56, S161. Fulltext not available.

Wanninger, J., Neumeier, M., Bauer, S., Weiss, Thomas S. , Hellerbrand, C., Schoelmerich, J. and Buechler, Christa (2011) Antifibrotic effects of adiponectin include induction of BMP-activated and membrane bound inhibitor (Bambi) in liver cells which antagonizes TGF-beta activity. Zeitschrift für Gastroenterologie 49, pp. 1-56. Fulltext not available.

Stickel, F., Buch, S., Lau, K., zu Schwabedissen, H. Meyer, Berg, T., Ridinger, M., Wiegandt, S., Rietschel, M., Schafmayer, C., Braun, F., Hinrichsen, H., Günther, R., Arlt, A., Seeger, M., Mueller, S., Seitz, H.K., Soyka, M., Lerch, M. , Lammert, F., Sarrazin, C., Kubitz, R., Häussinger, D., Hellerbrand, C., Schölmerich, J., Wittenburg, H., Bröring, D., Schreiber, S., Spanagel, R., Mann, K., Krawczak, M., Wodarz, N., Völzke, H. and Hampe, J. (2010) 1183 GENETIC VARIATION IN THE PNPLA3 GENE IS ASSOCIATED WITH ALCOHOLIC LIVER INJURY IN CAUCASIANS. Journal of Hepatology 52, S459. Fulltext not available.

Kirovski, G., Amann, T., Bosserhoff, A. and Hellerbrand, C. (2010) 559 ANALYSIS OF A PROMOTER POLYMORPHISM OF THE GLUT1 GENE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. Journal of Hepatology 52, S222-S223. Fulltext not available.

Quint, K., Agaimy, A., Steindorf, C., Hellerbrand, C. and Ocker, M. (2010) 582 EXPRESSION OF HDAC ISOENZYMES AS A PROGNOSTIC MARKER IN HEPATOCELLULAR CARCINOMA. Journal of Hepatology 52, S230. Fulltext not available.

Quint, K., Agaimy, A., Hellerbrand, C., Neureiter, D. and Ocker, M. (2010) 723 Expression of HDAC1, 2, 3 and 7 as a prognostic markers in hepatocellular carcinoma. European Journal of Cancer Supplements 8 (5), pp. 182-183. Fulltext not available.

Valletta, D., Amann, T., Bosserhoff, A.K. and Hellerbrand, C. (2010) 904 INCREASED EXPRESSION OF FAT1 IN HEPATOCELLULAR CARCINOMA PROMOTES TUMORIGENICITY. Journal of Hepatology 52, S351. Fulltext not available.

Dostert, K., Wiest, R., Schölmerich, J., Hellerbrand, C. and Gäbele, E. (2010) 928 DEFICIENCY OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) AGGRAVATES INFLAMMATION AND FIBROSIS IN EXPERIMENTAL NON ALCOHOLIC STEATOHEPATITIS BUT PROTECTS AGAINST BILE DUCT LIGATION INDUCED FIBROSIS IN VIVO. Journal of Hepatology 52, S360. Fulltext not available.

Zimmermann, H.W., Seidler, S., Nattermann, J., Gassler, N., Hellerbrand, C., Weiskirchen, R. , Trautwein, C. and Tacke, F. (2010) 999 HUMAN MONOCYTE SUBSETS ACCUMULATE INTRAHEPATICALLY IN LIVER CIRRHOSIS AND DIFFERENTIALLY INTERACT WITH HEPATIC STELLATE CELLS. Journal of Hepatology 52, S385-S386. Fulltext not available.

Buettner, R., Bettermann, I., Hechtl, C., Gäbele, E., Hellerbrand, C., Schölmerich, J. and Bollheimer, L. C. (2010) Dietary Folic Acid Activates AMPK and Improves Insulin Resistance and Hepatic Inflammation in Dietary Rodent Models of the Metabolic Syndrome. Hormone and Metabolic Research 42 (11), pp. 769-774. Fulltext not available.

Stickel, F. and Hellerbrand, C. (2010) Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut 59 (10), pp. 1303-1307. Fulltext not available.

Dorn, C., Froh, M., Schuster, K., Schölmerich, J., Blank, C. and Hellerbrand, C. (2008) 151 PROTECTIVE EFFECT OF PD-L1/PD-1 IN ACUTE HEPATIC ISCHEMIA-REPERFUSION INJURY. Journal of Hepatology 48, S66. Fulltext not available.

Amann, T., Maegdefrau, U., Kreuz, M., Hartmann, A., Schoelmerich, J., Bosserhoff, A.K. and Hellerbrand, C. (2008) 318 GLUT1 EXPRESSION IS INCREASED IN HEPATOCELLULAR CARCINOMA AND PROMOTES TUMORIGENESIS. Journal of Hepatology 48, S126. Fulltext not available.

Wirz, W., Antoine, M., Tag, C.G., Gressner, A.M., Korff, T., Hellerbrand, C. and Kiefer, P. (2008) Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation 76 (7), pp. 784-794. Fulltext not available.

Osterreicher, C. H., Schultheiss, J., Wehler, M., Homann, N., Hellerbrand, C., Kunzli, B., Friess, H., Seitz, H. K. and Stickel, F. (2007) Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis. Mutagenesis 22 (5), pp. 305-310. Fulltext not available.

Hellerbrand, C., Bumes, E., Bataille, F., Dietmaier, W., Massoumi, R. and Bosserhoff, A. K. (2007) Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28 (1), pp. 21-27. Fulltext not available.

Scholten, D., Dahl, E., Beraza, N., Lammert, F., Hellerbrand, C., Weiskirchen, R. , Weber, C., Trautwein, C. and Wasmuth, H.E. (2007) [104] FUNCTIONAL AND GENETIC INTERACTION OF THE CHEMOKINES CCL (RANTES) AND CXCL (PF) IN CHRONIC LIVER DISEASES IN MICE AND HUMANS. Journal of Hepatology 46, S46. Fulltext not available.

Froh, M., Walbrun, P., Netter, S., Wiest, R., Schoelmerich, J. and Hellerbrand, C. (2007) [130] ADENOVIRAL GENE DELIVERY OF INTERLEUKIN-10 REDUCES HEPATIC ISCHEMIA-REPERFUSION INJURY IN RATS THRU INHIBITION OF KUPFFER CELL ACTIVATION. Journal of Hepatology 46, S59. Fulltext not available.

Moreno Zaldiva, M., Scholten, D., Schmitz, P., Hellerbrand, C., Dahl, E., Weiskirchen, R., Trautwein, C. and Wasmuth, H.E. (2007) [453] ASSOCIATION OF CCBP2, A SCAVENGER RECEPTOR FOR INFLAMMATORY CC CHEMOKINES, WITH LIVER INFLAMMATION IN MICE AND HUMANS. Journal of Hepatology 46, S172-S173. Fulltext not available.

Amann, T., Spruss, T., Bataille, F., Liedtke, C., Muhlbauer, M., Trautwein, C., Bosserhoff, A.K. and Hellerbrand, C. (2007) [69] IDENTIFICATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2IIIB (FGFR2IIIB) AS TUMOR SUPPRESSOR IN HEPATOCANCEROGENESIS. Journal of Hepatology 46, S31. Fulltext not available.

Mühlbauer, M., Fleck, M., Weiss, Thomas S. , Froh, Matthias, Schütz, C., Blank, C., Schölmerich, Jürgen and Hellerbrand, C. (2006) PD-L1 expression in human hepatocytes induces T-cell apoptosis. Medizinische Klinik 101 (4), A23. Fulltext not available.

Wrede, C. E., Buettner, R., Bollheimer, L. C., Schölmerich, J., Palitzsch, K.-D. and Hellerbrand, C. (2006) Association between serum ferritin and the insulin resistance syndrome in a representative population. European journal of endocrinology / European Federation of Endocrine Societies 154 (2), pp. 333-340. Fulltext restricted.

Wasmuth, H.E., Hillebrandt, S., Scholten, D., Dahmen, J., Hellerbrand, C., Berg, T., Trautwein, C. and Lammert, F. (2006) 109 The chemokine CXCL9 (MIG) is associated with liver fibrogenesis in mice and humans. Journal of Hepatology 44, S47. Fulltext not available.

Hellerbrand, C., Amann, T., Schlegel, J., Spruss, T., Bataille, F., Hartmann, A., Mühlbauer, M., Schölmerich, J. and Bosserhoff, A.K. (2006) 98 The novel gene MIA2 promotes progression of hepatocellular carcinoma. Journal of Hepatology 44, S43. Fulltext not available.

Lock, G., Dirscherl, M., Obermeier, F., Gelbmann, C. M., Hellerbrand, C., Knöll, A., Schölmerich, J. and Jilg, W. (2006) Hepatitis C – contamination of toothbrushes: myth or reality? Journal of Viral Hepatitis 13 (9), pp. 571-573. Fulltext not available.

Mühlbauer, M., Allard, B., Bosserhoff, A. K. , Kiessling, S., Herfarth, H., Rogler, G. , Schölmerich, J., Jobin, C. and Hellerbrand, C. (2004) Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-κB signal transduction and IL-8 gene expression in colonic epithelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology 286 (6), G1000-G1008. Fulltext not available.

Bosserhoff, A.K., Hellerbrand, C. and Buettner, R. (2001) Klinische und genetische Aspekte der hereditären Hämochromatose. Der Pathologe 22 (3), pp. 191-196. Fulltext not available.